Zobrazeno 1 - 10
of 91
pro vyhledávání: '"Noriko Koizumi"'
Autor:
Yasufumi Tomioka, Koji Kitazawa, Hideki Fukuoka, Morio Ueno, Noriko Koizumi, Chie Sotozono, Shigeru Kinoshita
Publikováno v:
American Journal of Ophthalmology Case Reports, Vol 30, Iss , Pp 101839- (2023)
Purpose: To report the safety, efficacy, and long-term outcome in a case of Fuchs endothelial corneal dystrophy (FECD) treated by Rho-associated protein kinase (ROCK)-inhibitor eye drops in combination with removal of degenerated corneal endothelial
Externí odkaz:
https://doaj.org/article/2c070629582049868a3d848b39ff53d5
Publikováno v:
Journal of Ophthalmology, Vol 2017 (2017)
ROCK (Rho kinase) signaling regulates a wide spectrum of fundamental cellular events and is involved in a variety of pathological conditions. It has therefore attracted research interest as a potential therapeutic target for combating various disease
Externí odkaz:
https://doaj.org/article/7a07b1481e8c46889a7517884d651f8b
Autor:
Alina Akhbanbetova, Shinichiro Nakano, Stacy L. Littlechild, Robert D. Young, Madara Zvirgzdina, Nigel J. Fullwood, Ian Weston, Philip Weston, Shigeru Kinoshita, Naoki Okumura, Noriko Koizumi, Andrew J. Quantock
Publikováno v:
Journal of Ophthalmology, Vol 2017 (2017)
Purpose. To examine the effects of transcorneal freezing using a new cryoprobe designed for corneal endothelial surgery. Methods. A freezing console employing nitrous oxide as a cryogen was used to cool a series of different cryoprobe tip designs mad
Externí odkaz:
https://doaj.org/article/53de991711b74fd8917909f35f9e2f92
Publikováno v:
Journal of Ophthalmology, Vol 2017 (2017)
Purpose. The purpose of this study was to investigate the feasibility of poly lactic/glycolic acid (PLGA) as a drug delivery carrier of Rho kinase (ROCK) inhibitor for the treatment of corneal endothelial disease. Method. ROCK inhibitor Y-27632 and P
Externí odkaz:
https://doaj.org/article/30cdef296234492d851f0b0ed60ceb42
Autor:
Naoki Okumura, Munetoyo Toda, Kohsaku Numa, John Bush, Motomu Tanaka, Noriko Koizumi, Junji Hamuro, Akihisa Yamamoto, Kojiro Imai, Shigeru Kinoshita, Hiroshi Tanaka, Chie Sotozono, Satoshi Teramukai, Morio Ueno
Publikováno v:
American Journal of Ophthalmology. 237:267-277
PURPOSE To investigate the safety and efficacy of cultured human corneal endothelial cell (hCEC)-injection therapy with mature differentiated (mature) cell subpopulations (SPs) for corneal endothelial failure (CEF). DESIGN Comparative, interventional
Autor:
Inès Aouimeur, Vaitinadapoule Hanielle, Okumura Naoki, Noriko Koizumi, Philippe Gain, Gilles Thuret, Zhiguo He
Publikováno v:
Acta Ophthalmologica. 100
Autor:
Oliver Dorado Cortez, Emmanuel Crouzet, Sylvain Poinard, Philippe Gain, Thibaud Garcin, Naoki Okumura, Noriko Koizumi, Gilles Thuret
Publikováno v:
Acta Ophthalmologica. 100
Autor:
Yuya Komori, Zhiguo He, Noriko Koizumi, Gilles Thuret, Makiko Nakahara, Philippe Gain, Naoki Okumura, Masakazu Sato
Publikováno v:
Cell and Tissue Banking. 22:551-562
In 2013, a clinical trial was initiated to investigate cell therapy for the treatment of corneal endothelial decompensation. Cultivating human corneal endothelial cells (CECs) while maintaining their functional phenotype is challenging; therefore, es
Autor:
Vasanthi Padmanaban, Naoya Hanada, Thenmozhi Velumani, Naoki Okumura, Noriko Koizumi, Taisuke Hirono, Farhath Hadiya, Sangly P. Srinivas, Yuya Komori, Prema Padmanabhan
Publikováno v:
Cornea. 40:1445-1452
Purpose The aim of this study was to investigate the immune cells on corneal endothelium of the graft in patients who underwent penetrating keratoplasty (PK), Descemet-stripping endothelial keratoplasty (DSEK), and Descemet membrane endothelial kerat
Autor:
Koji Kitazawa, Chie Sotozono, Hiroshi Tanaka, Noriko Koizumi, Kojiro Imai, Naoki Okumura, Kohsaku Numa, Morio Ueno, John Bush, Satoshi Teramukai, Junji Hamuro, Shigeru Kinoshita
Publikováno v:
Ophthalmology. 128:504-514
Purpose To report the safety and efficacy of a novel cell injection therapy using cultured human corneal endothelial cells (hCECs) for endothelial failure conditions via the report of the long-term 5-year postoperative clinical data from a first-in-h